Nicholas N. Vahanian
2013
In 2013, Nicholas N. Vahanian earned a total compensation of $1.3M as President & Chief Medical Officer at NewLink Genetics, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,000 |
|---|---|
| Option Awards | $673,779 |
| Salary | $420,000 |
| Other | $27,405 |
| Total | $1,310,184 |
Vahanian received $673.8K in option awards, accounting for 51% of the total pay in 2013.
Vahanian also received $189K in non-equity incentive plan, $420K in salary and $27.4K in other compensation.
Rankings
In 2013, Nicholas N. Vahanian's compensation ranked 5,475th out of 12,286 executives tracked by ExecPay. In other words, Vahanian earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,475 out of 12,286 | 55th |
Division Manufacturing | 1,908 out of 4,612 | 59th |
Major group Chemicals And Allied Products | 550 out of 1,462 | 62nd |
Industry group Drugs | 392 out of 1,156 | 66th |
Industry Pharmaceutical Preparations | 314 out of 890 | 65th |
Source: SEC filing on April 6, 2016.
Vahanian's colleagues
We found four more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2013.